A: Replacement of current invasive procedure | Establishment of noninferior accuracy |
B: Improved accuracy of initial diagnosis | Estimation of effect of delayed diagnosis |
C: Improved accuracy of staging for curative treatment vs. palliative treatment | PET/CT provides no benefit for survival |
D: Improved accuracy of staging for radiation vs. chemotherapy | Comparability of changers with all patients |
E: Response evaluation | Efficient second-line therapy implies imperfect gold standard |
F: Rapid decision | Lack of agreement on benefit of rapid decision |